Thus, the STIF-architecture appears to be particularly suited to engineer genetic sensors for various proteins of interest such as cancer-related fusion proteins that include, but evidently not limited to BCR-ABL (Supplementary information, Fig. S9d). Here, ABL1 is linked to cancer.